baber/WOPTO huggingface dataset:
Patent NZ-543231-A (NZ)
Title: Low surface area shearing device
Inventor: GRUBBA BILL
IPC: E01C19/18
Filed: 2004-03-30
Abstract: An apparatus (10) for use in shearing paving material applied to a surface is provided. The apparatus includes a blade (80) for shearing the asphalt mixture to a desired thickness, cylinders (56) for raising and lowering the blade in response to elevational changes in the surface, at least one signal generator (110) associated with each cylinder and adapted to produce a signal indicative of the elevation of the surface, and at least one signal receiver (112) associated with each signal generator. The blade apparatus is coupled with a prime mover (14). The receiver is operable to activate the cylinders in response to a signal received from the generator. The blade is raised and lowered as the elevation of the surface changes in response to signals emanating from the generator allowing surface level variations to be evened out while paving.
Patent NZ-543976-A (NZ)
Title: Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
Inventor: BRATT TOMAS
IPC: C12N15/28
Filed: 2004-05-06
Abstract: Disclosed is an immunogenic analogue of a human TNFalpha protein, wherein said analogue comprises an immunogenized monomeric TNFalpha polypeptide or TNFalpha di- or trimer. The analogue further comprises a toxicity reducing or abolishing mutation selected from the group consisting of Y87S, D143N or A145R, the amino acid numbering setting out from the N-terminal valine in human TNFalpha. Also disclosed is a nucleic acid fragment encoding the analogue as well as to vectors and transformed cells useful in the preparation of the analogue and methods of down-regulating TNFalpha in a subject in need thereof.
Patent NZ-549991-A (NZ)
Title: Preparation of syngas for acetic acid synthesis by partial oxidation of methanol feedstock
Inventor: THIEBAUT DANIEL MARCEL
IPC: C01B32/40
Filed: 2005-06-23
Abstract: Disclosed is a method for preparing a hydrogen-rich stream and a carbon monoxide-rich stream, comprising: reacting a methanol feed stream and oxygen, and optionally a temperature moderator, in a partial oxidation reactor to produce a syngas stream, wherein the partial oxidation reactor is catalyst-free and operated at a temperature between 1100 and 2000 degrees Celsius; separating the syngas stream into a carbon dioxide rich stream and a mixed stream containing hydrogen/carbon monoxide; and separating the mixed stream into a hydrogen-rich stream and a carbon monoxide-rich stream. Also disclosed is a method for converting an original methanol plant to a converted plant for the synthesis of acetic acid, the method comprising the steps of: providing the original methanol plant having at least one partial oxidation reactor for converting a hydrocarbon to a syngas stream containing hydrogen, carbon monoxide and carbon dioxide; and a methanol synthesis loop for converting hydrogen and carbon monoxide from the syngas stream to methanol; providing for supplying at least a portion of a methanol feedstock stream, oxygen from an air separation unit and optionally, a temperature moderator, to the at least one partial oxidation reactor, wherein the partial oxidation reactor is catalyst-free and operated at a temperature between 1100 and 2000 degrees Celsius; installing a first separation unit for separating a carbon dioxide-rich stream and a mixed hydrogen/carbon monoxide stream from the syngas effluent; installing a second separation unit for separating a hydrogen-rich stream and a carbon monoxide rich stream from the mixed stream; installing an acetic acid synthesis unit; providing for supplying the carbon monoxide-rich stream from the second separation unit and a portion of the methanol feedstock stream to the acetic acid synthesis unit; and installing isolation valves for isolating the methanol synthesis loop from the remainder of the converted plant.
Patent NZ-550715-A (NZ)
Title: Therapeutic heparins and their binding to IL- 5
Inventor: COOMBE DEIRDRE ROMA
IPC: A61P31/04
Filed: 2005-04-19
Abstract: Disclosed is a method for identifying an antagonist of interleukin-5 comprising the steps of: (i) immobilizing IL-5 to a solid support; (ii) (ii) generating a fraction of heparin and identifying the heparin fraction which binds to IL-5 at a location on IL-5 defined by amino acids R32, R67, K70, K76, K77, K83, K84, K85, R90, R91 and R92; (iii) Selecting the identified fraction of non-full length heparin from (ii) and screening for a compound which prevents binding of that fraction to the immobilized IL-5; (iv) Subjecting the compounds identified in (iii) to an assay to determine whether it antagonizes IL-5 activity; (v) Selecting the compound from (iv) which antagonizes IL-5 activity.
Patent NZ-553832-A (NZ)
Title: Method and apparatus for removing sheets of fibres from banana plants for the production of paper products
Inventor: AZER RAMY ABRAHAM
IPC: D21B1/00
Filed: 2005-09-15
Abstract: A method and apparatus for producing sheets from the pseudostems of banana plants in the family Musaceae, each pseudostem having a longitudinal axis. The method includes the steps of feeding a pseudostem (14) into a workstation, supporting (62, 34) the pseudostem for rotation thereof about its longitudinal axis within the workstation, and contacting the rotating pseudostem along substantially its entire length with a fibre-separating device (38), whereby a continuous sheet of fibre (60) is removed from the pseudostem by the fibre-separating device during rotation. Raw paper may also be made by laminating two or more of these sheets together such that the direction of the generally parallel fibres in at least two adjacent sheets is not aligned and then curing the sheets to form raw paper.
Patent NZ-555385-A (NZ)
Title: Sensor mounting assembly
Inventor: KNOLLES BRIAN ROBERT
IPC: G01K7/00
Filed: 2007-05-25
Abstract: A method of installation of a sensor mounting assembly and a sensor mounting assembly for a tank wall is disclosed. The tank has inner and outer walls, separated and having a space between. The assembly includes a conductive central sheath, a flexible outer covering, and retaining flange. The sensor is mounted within the sheath with the covering surrounding the sheath and the flange mounted at one end of the sheath. The sensor assembly is installed so that the sensor and sheath are compressibly mounted between the tank walls.
Patent NZ-556488-A (NZ)
Title: Improvements in large umbrellas
Inventor: LI JUN QIAO
Filed: 2007-07-13
Abstract: An umbrella has a base and a column which extends upwardly from the base and is pivotally mounted about a generally horizontal base. The column extends at an angle to the vertical upwardly to an umbrella canopy assembly including a depending centre shaft. An inclined support rod also extends upwardly from the base and is pivotally mounted to a tension rod whose upper end is mounted on the depending shaft. A handle is mounted to the tension rod associated with a locking means for locking the umbrella in an open position and preventing relative movement of the column, support rod and tension rod. Depression of the handle unlocks the locking means allowing relative movement of the column, support rod and tension rod to close the umbrella. The base also defines a turntable assembly which can be rotated relative to the base to allow the column and hence the canopy of the umbrella to rotate through 360o and defines a plurality of wheels which are mounted so that they can be retracted into the base or lowered to allow the base to roll along a surface which enables the base and umbrella to be more easily moved than existing beach type umbrellas which must be dragged or carried.
Patent NZ-561952-A (NZ)
Title: An ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
Inventor: TJADER TAINA
IPC: A61F/
Filed: 2006-04-04
Abstract: An ultrasonically detectable intrauterine system (IUS) for long-term insertion into a uterine cavity comprises at least one image enhancing means for improving the ultrasound imaging of the system. The means are selected from the group consisting of a) at least one inert metal clip, pin, ring and/or sleeve fixedly positioned and at least partly embedded in the body of the intrauterine system; and b) a inert metallic loop anchored to the vertical arm of the body of the intrauterine system in place of the usual loop. The inert metal is selected from the group consisting of silver, gold, titanium, tungsten, bismuth, platinum and palladium.
Patent NZ-572048-A (NZ)
Title: Method for treatment of diarrhea-predominant irritable bowel syndrome
Inventor: QUART BARRY
IPC: A01N65/00
Filed: 2007-04-30
Abstract: Disclosed is the use of an inhibitor as herein defined for the manufacture of a medicament for treating pain associated with diarrhea-predominant IBS (d-IBS), or abdominal discomfort associated with d-IBS, wherein the inhibitor is selected from the group consisting of an extract from Croton spp. or Calophyllum spp., latex from Croton spp. or Calophyllum spp., proanthocyanidin polymer composition from a Croton species or a Calophyllum species, and crofelemer, wherein the amount of inhibitor is bioequivalent to crofelemer at a dosage of 50 mg per day to 750 mg per day.
Patent NZ-573265-A (NZ)
Title: Method for inhibiting color fading in color-treated hair by contact with lauryltrimonium chloride or cocotrimonium chloride
Inventor: VERBOOM GILLES
IPC: A61K8/41
Filed: 2007-06-05
Abstract: Disclosed is a method for inhibiting colour / color fading in colour-treated / color-treated hair and enhancing the intensity of colour achieved by colour-treating hair, the method comprising contacting the hair with a composition comprising a carrier and a color fading inhibiting-effective amount of from about 0.1 weight per cent to about 15 weight per cent of a monoalkyl quaternary ammonium salt, which is lauryltrimonium chloride, cocotrimonium chloride, or a combination thereof, wherein the monoalkyl quaternary ammonium salt in the composition exclusively inhibits fading of color in color-treated hair.
Patent NZ-585779-A (NZ)
Title: Storage assembly and method for storing elongate goods with first and seccond elevating conveyors and bi-directional storage conveyor.
Inventor: EBNER FRANZ
IPC: B65G47/51
Filed: 2008-10-29
Abstract: The invention relates to a storage assembly (10) and a method of storing elongated piece goods (5), consisting in particular of wood. A first elevating cross conveyor (1) is situated on a first side (11) of the storage assembly (10) and a second elevating cross conveyor (2) is situated on the second side (12) of the storage assembly (10). At least two storage levels (3) are situated between the first elevating cross conveyor (1) and the second elevating cross conveyor (2). Each of the storage planes (3) comprises at least one storage cross conveyor (4) provided in order to transport the elongated timber goods (5) between the first elevating cross conveyor (1) and the second elevating cross conveyor (2).
Patent NZ-588792-A (NZ)
Title: Generating an interface including selectable resource items and displaying usage data of resources
Inventor: MOORE CAMERON STEWART
IPC: G06Q30/02
Filed: 2009-04-24
Abstract: Disclosed is a usage data analysis system including an application server, selectable identifiers and selectable views. The selectable identifiers are associated with items to enable selection of items for display as filtered items according to the selected identifier. The selectable views are configured for presenting data associated with the filtered items, including at least one of: demographic data associated with users of the items; numbers of users of the items; comparison data between the filtered items; geographic data associated with the location of the users; and tag map data based on the filtered items having tags associated with the items, and presenting the relationship between the tagged items. The application server is configured to generate a user interface (2200) on a client computer device for displaying resource item usage. Generating a user interface includes generating data representing a display, in a first part of the interface (2220), of available resource items associated with usage data. Usage data represents usage of the resource items, which are selectable using the interface. The application server also receives data representing a selection by a user, using the interface, of a plurality of resource items from the available resource and generates data representing a display of the selected resource items in a second part of the interface (2234). The application server is also configured for filtering the usage data to select one or more usage data relating to the selected resource items and receiving data representing a selection by the user, using the interface, of a view associated with at least one property of the selected resource items. The application server is further configured for selecting ones of the filtered usage data that are associated with the at least one property and generating data representing a report for displaying, in a third part of the interface (2218), the view using the selected ones of the filtered usage data.
Patent NZ-588960-A (NZ)
Title: Tetrahydroindolone and tetrahydroindazolone derivatives
Inventor: HUANG KENNETH HE
IPC: A61K31/404
Filed: 2006-02-27
Abstract: Disclosed are 4-(4-oxo-4,5,6,7-tetrahydroindazol-1-yl)-benzamide and 4-(4-oxo-4,5,6,7-tetrahydro-indol-1-yl)-benzamide derivatives as represented by the general formula (XXV), wherein: X1 is N or CRc; R3 and R4 are independently, H, halo, or optionally substituted alkyl, or R3 and R4 together with the atoms to which they are attached form a 5-12 membered mono-, bi-, or tricyclic ring system fused to the ring containing Q1 and Q2, where the 5-12 membered ring is partially unsaturated or aromatic and optionally contains one or two of oxygen, S(O)m , nitrogen, or NR33; and wherein the remaining substituents are as defined herein. Representative compounds include 2-(cyclopropylamino)-4-(3-methyl-4-oxo-4,5,6,7-tetrahydroindol-1-yl)benzamide, 4-(3-methyl-4-oxo-4,5,6,7-tetrahydroindol-1-yl)benzamide and 2-[(2-methoxyethyl)amino]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide. Further disclosed is a pharmaceutical composition which comprises at least one compound or salt as defined above and a pharmaceutically acceptable solvent, carrier, excipient, adjuvant or a combination thereof, for the treatment of a disease or disorder of proteins that are either client proteins for HSP-90 or indirectly affect its client proteins, wherein said disorder is selected from the group of inflammatory diseases, infections, autoimmune disorders, stroke, ischemia, cardiac disorders, neurological disorders, fibrogenetic disorders, proliferative disorders, tumors, leukaemia, neoplasms, cancer, carcinomas, metabolic diseases, malignant disease, sclerodenna, polymyositis, systemic lupus, rheumatoid arthritis, liver cirrhosis, keloid formation, interstitial nephritis, and pulmonary fibrosis.
Patent NZ-590363-A (NZ)
Title: Method of improving the cold flow properties of a paraffin-containing fluid
Inventor: RODRIGUEZ GONZALEZ RAQUEL
IPC: C08F26/06
Filed: 2009-07-03
Abstract: Disclosed is a method of improving the cold flow properties of a paraffin-containing fluid comprising wax-containing oils, natural gas liquids, crude oil, shale oil, petroleum, and/or tar sands oil, and/or mixtures thereof, wherein the method comprises: admixing with the paraffin-containing fluid an effective amount of a copolymer comprising: cyclic amide monomers (preferably vinyl pyrrolidone or vinyl caprolactam monomers) and long-chain alkyl monomers (preferably acrylate ester or acrylamide monomers).
Patent NZ-591040-A (NZ)
Title: Method for treating feed silage for ruminants by treatment with at least two microbes selected from specific Lactobacillus, Enterococcus, Trichosporon strains
Inventor: BINDER EVA MARIA
IPC: A23K1/18
Filed: 2009-06-26
Abstract: Discloses a method for treating feed silage for ruminants. The silage is mixed with a microorganism and stored in a closed container for at least 30 days. The feed silage is mixed with least two microorganisms selected from the group consisting of Enterococcus faecium DSM 3530, Lactobacillus brevis DSM 19456, Lactobacillus plantarum DSM 19457, Lactobacillus kefiri DSM 19455, Trichosporon spec. nov. DSM 14153, Trichosporon mucoides DSM 14156, Trichosporon dulcitum DSM14162, and Eubacterium DSM 11798, as well as a silicate having a large internal surface area. Further discloses a feed silage additive for ruminants, containing silage of grass, cereals, maize and/or lucernes as well as at least microorganisms as disclosed above. Further discloses that for each selection of microbes at least one microorganisms must be heterofermentative and least one of the microorganisms must be homofermentative.
Patent NZ-591134-A (NZ)
Title: Cross-species-specific (human and primate) bispecific single chain antibody that binds both cd3 (epsilon) epitope and prostate specific membrane antigen (pmsa)
Inventor: KUFER PETER
IPC: C07K16/28
Filed: 2009-10-01
Abstract: Discloses a bi-specific single chain antibody molecule comprising a: 1. first binding domain which is an antigen-interaction site, capable of binding to an epitope of human and Callithrix jacchus, Saguinus oedipus or Saimiri sciureus CD3å (epsilon) chain, where the epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs: 2, 4, 6, or 8, and comprises at least the amino acid sequence Gln-Asp-Gly-Asn-Glu; and 2. a second binding domain capable of binding to prostate-specific membrane antigen (PSMA). Further disclosed is a pharmaceutical composition comprising the said bi-specific single chain antibody molecule. The therapeutic application is for the provision of a dual variable binding domain antibody that may be used in the treatment of certain cancers positive for the PSMA antigen or CD3å epiptope.
Patent NZ-594443-A (NZ)
Title: Nucleic acid purification
Inventor: SELDEN RICHARD F
IPC: B01L3/00
Filed: 2010-02-03
Abstract: Disclosed is a self-contained apparatus which isolates nucleic acid from a biological sample for rapid DNA analysis. The self-contained apparatus may be a cartridge. The self-contained apparatus is to be used with an instrument, which may then additionally process the resulting isolated nucleic acid, such as by DNA sequencing. The self-contained apparatus comprises a macrofluidic component (3) and a microfluidic component in communication with the microfluidic component (4) via at least one microfluidic element. Formed within the macrofluidic component are a chamber (see 16, figure 4), for receiving an unprocessed biological sample from a collection device (1), at least two pre-filled lysis reagent storage reservoir (see 11 & 13, figure 4), a wash reagent storage reservoir (see 6, figure 4) pre-filled with wash reagent, and an elution reagent storage reservoir (see 9, figure 4) pre-filled with elution reagent. The microfluidic component further comprises at least one drive line (see 20, figure 6) and at least one nucleic purification matrix (see 22, figure 6). The self-contained apparatus only comprises two inputs; one being the aforementioned chamber, for receiving the sample from a collection device, and the other input being a pneumatic interface port (5). This is advantageous in that the user does not need to add reagents, as they are already on-board and pre-filled within the apparatus, thereby simplifying the process of isolating nucleic acid and avoiding the risk of contaminating the reagents. In use, a drive mechanism of the instrument drives lysis reagents, wash reagent and elution reagent sequentially through the microfluidic element and nucleic acid purification matrix via pneumatic pressure through the pneumatic interface port. The self-contained apparatus provides a simple means of nucleic acid isolation that eliminates the need for trained, technical users, working in sophisticated laboratories. Methods of purifying nucleic acids from an unprocessed sample are also disclosed.
Patent NZ-596966-A (NZ)
Title: Process and system for efficient allocation of medical resources
Inventor: WACHTELL PETER JAMES
IPC: G06Q50/22
Filed: 2010-06-08
Abstract: 596966 Disclosed is a computer system with a database (402) accessible by the processor and including patient medical records. A computer readable storage medium (401) is included and contains a set of instructions (403) configured to carry out a method of allocating medical resources with improved efficiency. The method involves accessing the database (402) to retrieve medical data for a population of patients such that the population includes patients who have been diagnosed as having a disease and patients who have not yet been evaluated and diagnosed as having the disease. One or more best practice guidelines are identified for disease management of the disease across the entire population. A subset of patients is then determined in the population that are not being treated based on the identified best practice guidelines for the disease. Determining the subset of patients involves (a) identifying a first sub-population of patients at relatively high risk as having the disease compared to other patients in the population, but who have not yet been diagnosed as having the disease, and (b) identifying patients that have been diagnosed as having the disease, but for which the best practice guidelines have not been followed. Audit data is generated for the subset of patients and reasons for a medical professional examining the subset of patients and the subset of patients for order of treatment are prioritised. Prioritising involves assigning a value to each patient and generating a rank ordering for treatment of the patients based on the assigned values. The value assigned to each patient is determined by taking into account one or more variables chosen from the patient’s compliance or lack of compliance with the identified best medical practice guidelines, availability of medical treatment resources, time expenditure requirements for treating the patient, historical performance of the patient, historical performance of the medical treatment facility or net revenues for caring for the patient. A weighting value is assigned to at least one of the variables which determines the importance of the variable in prioritizing the order for scheduling patients.
Patent NZ-599154-A (NZ)
Title: Method and system for controlled fusion reactions
Inventor: BIRNBACH CURTIS A
IPC: G21B1/03
Filed: 2007-05-30
Abstract: 599154 Disclosed is a system for extracting energy from inertial confinement fusion reactions. The system includes: a central target chamber (10) for receiving a fusion target (at 22); a plurality of energy drivers (12); means for controlling the energy drivers (12); and a plurality of means for extracting energy (14, 20) from fusion reactions. The energy drivers (12) are at least six in number and are arranged in symmetrical pairs around the exterior of the target chamber (10). The energy drivers (12) directly supply synchronous x-ray pulse energy to the fusion target (at 22) in the chamber (10) to initiate a fusion reaction of the target (at 22) and release energy in the forms of fusion plasma and heat. The energy drivers (12) are oriented so as to each supply a synchronous x-ray pulse to the fusion target (at 22) in a 3-dimensionally symmetric manner about the fusion target (at 22), the fusion target (at 22) being in the form of a spherical pellet. The means for controlling the energy drivers (12) are arranged to control the energy drivers (12) to synchronously supply X-ray energy exclusively in pulse form to the fusion target (at 22) to initiate the fusion reaction. The means for extracting energy (14, 20) from the fusion reactions include means (14) to extract high voltage DC energy from the fusion plasma; and means (20) to extract thermal energy from the central target chamber (10).